Análisis Argos
MD
MDEn su precio
Pediatrix Medical Group, Inc. · Healthcare
US$ 26.76
precio al 2026-07-04
Valor justo Argos*
US$ 19–24
vs. su valor justo
54% por encima
Score Argos
64/100
En su precio
LA RESPUESTA
El precio asume un crecimiento (3.3%) en línea con lo que la empresa demuestra (0.8%). Ni ganga ni exceso — el mercado le puso un precio razonable.
Recompensas
Cotiza 19% por debajo de su valor justo.
Retorno sobre el capital alto (15%).
Riesgos
Sin riesgos destacados.
VALOR3/6FUTURO0/6PASADO4/6SALUD3/6DIVIDENDO4/6
El Iris de calidad
VALOR3/6FUTURO0/6PASADO4/6SALUD3/6DIVIDENDO4/6
ValorCerca de su valor justo
FuturoIngresos estancados o cayendo
PasadoFundamentales sólidos y sostenidos
SaludBalance razonable
DividendoDevuelve capital al accionista
Score Argos64de 100En su precio
Ingresos5%
US$ 1.9 B
Margen operativo456%
12.1%
Flujo de caja libre39%
US$ 0.3 B
Deuda neta
US$ 0.3 B
Lo esencial, sin ruido
Cap. de mercadoUS$ 2.2B
P/E13.3x
EV/EBITDA9.8x
FCF yield11.5%
ROIC15.3%
Margen operativo12.1%
Crecim. ingresos-4.9%/año
Piotroski F7/9
Competidores

Los rivales, con el mismo ojo

El Iris de calidad de cada competidor, lado a lado. Tocá uno para ver su análisis.

Novedades

Noticias recientes

zacks.com · 26 jun
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.com · 23 jun
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
businesswire.com · 23 jun
New CV APP Compensation and Utilization Survey Report Highlights Growing APP Contributions, Prompting Focus on Support and Compensation
JACKSONVILLE BEACH, Fla.--(BUSINESS WIRE)--MedAxiom, the premier source for cardiovascular organizational performance solutions, has released the 2025 Cardiovascular Advanced Practice Provider (APP) Compensation and Utilization Report, which includes data from more than 100 provider organizations. The report features a foreword from Jerry Blackwell, MD, MBA, FACC, president and CEO of MedAxiom, highlighting APP contributions to productivity, workflow, access, and patient satisfaction, enabling.
globenewswire.com · 22 jun
Maryland Public Television earns 20 regional Emmy® Awards
OWINGS MILLS, MD, June 22, 2026 (GLOBE NEWSWIRE) -- The National Capital Chesapeake Bay Chapter of the National Academy of Television Arts & Sciences presented Maryland Public Television with 20 Emmys during its 68th Capital Emmy® Awards ceremony at the Bethesda North Marriott Hotel and Conference Center on Saturday, June 20. NATAS-NCCB comprises television industry professionals dedicated to fostering and recognizing outstanding achievements in television production in Maryland, Virginia, and Washington, D.C.
globenewswire.com · 17 jun
New Anglia University Responds to Rising Competition for Medical School Places in the UK
George Hill, Anguilla, 17 June 2026 -- As competition for medical school places in the United Kingdom reaches unprecedented levels, New Anglia University is providing aspiring doctors with an alternative pathway to medical education through its UK-aligned Doctor of Medicine (MD) programme, which combines an integrated curriculum with extensive NHS-based clinical rotations. The University's approach comes at a time when demand for medical school places continues to significantly exceed available capacity, leaving thousands of qualified applicants without a place each year despite strong academic credentials and a clear commitment to pursuing a career in medicine.
businesswire.com · 11 jun
Onera Will Showcase Its Onera hPSG® Solution at the SLEEP 2026 Conference June 14-17, 2026 in Baltimore, MD, USA.
EINDHOVEN, Netherlands--(BUSINESS WIRE)-- #MedicalDevice--Onera Health, a leader in transforming sleep medicine, announces that its end-to-end home polysomnography solution, the Onera hPSG® solution, will be prominently featured in multiple scientific presentations at the forthcoming SLEEP 2026 conference. The medtech company will showcase this innovative solution at booth #600 during the largest annual sleep medicine conference, which brings together leading experts and innovators in the field. Furthermore, in.
zacks.com · 10 jun
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
globenewswire.com · 4 jun
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
BRISANE, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest” or “Tempest Therapeutics”) today announced the appointment of two independent directors, Drake Richey and John Yee, MD, MPH to its Board of Directors (the “Board”), effective [June 4, 2026]. Mr. Richey and Dr. Yee collectively bring decades of experience in corporate finance and therapeutic product development to the Board.

* Valor justo Argos: estimación educativa del valor intrínseco según el propio flujo de caja de la empresa y su capacidad de crecimiento — no un precio objetivo ni una recomendación. Esto es información y educación, no asesoría de inversión. Rendimiento pasado no garantiza resultados futuros.